Invention Grant
- Patent Title: Compositions derived from Galenia Africana and methods of use for cancer treatment
-
Application No.: US16472690Application Date: 2017-12-19
-
Publication No.: US11040079B2Publication Date: 2021-06-22
- Inventor: Michael-John Joseph Barry
- Applicant: BIOPHARM NZ LIMITED
- Applicant Address: NZ Hamilton
- Assignee: BIOPHARM NZ LIMITED
- Current Assignee: BIOPHARM NZ LIMITED
- Current Assignee Address: NZ Hamilton
- Agency: Stites & Harbison, PLLC
- Agent Stephen J. Weyer, Esq.
- Priority: ZA2016/08789 20161221
- International Application: PCT/IB2017/058097 WO 20171219
- International Announcement: WO2018/116146 WO 20180628
- Main IPC: A61K36/185
- IPC: A61K36/185 ; A61K36/36 ; A61P35/00 ; A61K31/353 ; A61K45/06
Abstract:
The present invention discloses a cancer treatment method which includes the step of treating a patient having cancer with an extract from Galenia Africana L. plant. The extract may include pinocembrin and/or 2′,4′ dihydroxychalcone and/or 7-hydroxyflavanone. The cancer may be breast cancer or melanoma. The composition may be solubilized with MPG and/or Suganate.
Information query
